drugset / Trial / NCT00746980
Efalizumab in the Treatment of Alopecia, Phase II
NaSingle-groupOpen-labelTreatment
Summary
Determine the effect that treatment with efalizumab has on scalp hair re-growth in younger adults affected by severe variants of alopecia areata, including alopecia totalis, alopecia universalis, and severe ophiasis variants.
Timeline
- Start
- 2008-08
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | efalizumab | Monoclonal antibody | 1 mg/kg | Subcutaneous |